Check out which companies are making headlines before the bell:
Netflix–Goldman Sachs upgraded Netflix to "buy" from "neutral", citing the company's international expansion and the opportunity to increase profit margins as its customer base grows larger.
comScore–Goldman upgraded the stock to "buy" from "neutral", saying comScore was the firm's favorite stock to take advantage of the need to measure online traffic.
Urban Outfitters–Wedbush downgraded the retailer to "neutral" from "outperform", saying promotions at the company's Anthropologie unit could mean a slowdown in sales.
General Motors– The embattled auto maker continues to be a stock to watch, after announcing the recall of an additional 8.23 million cars during the trading day yesterday. Investors will also give special attention to GM's numbers for June to gauge the impact on sales.
Actavis–The company won Federal Trade Commission approval for its purchase of U.S. drug maker Forest Labs, with conditions. Actavis will be required to sell the rights to four generic drugs. The $25 billion transaction has already been approved by shareholders of both companies.
Boeing–The aerospace giant delivered its first 787-9 model to Air New Zealand. The move allows Boeing to book the delivery of the stretched version of the Dreamliner in its second quarter results.
Novartis– The drug maker will see its Japan unit charged with manipulating data relating to its blood pressure drug Diovan. An ex-employee will also be arrested in connection with the case, according to Tokyo prosecutors.
Las Vegas Sands, Wynn Resorts–Casino companies will be on watch today after gambling revenue in Macau fell 3.7 percent in June. That marked the first decline in more than four years, with analysts pointing to betting on the World Cup diverting money and gamblers away from the Macau casinos.
BB&T–The bank has been assessed $8.1 million in damages by a jury, in a case involving a former advisor who sold his wealth management business to the bank.
Hormel–Hormel is buying CytoSport Holdings for $450 million. CytoSport is the maker of Muscle Milk and other fitness-related nutrition products.
—By CNBC's Peter Schacknow
Questions? Comments? Email us at email@example.com